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patients who died during follow-up in both A and P treated patients separately.
Results: In both A and P arm, patients who died had significantly greater LF-values than
survivors (A 47.7± 11.0 vs 45.7± 7.5, p=0.03; P 53.6± 9.4 vs 48.8± 7.4, p<0.005). In both
survivors and those who died, LF-values on A were significantly smaller than on placebo
(p<0.005 in both comparisons). 
Conclusions: In high-risk post-MI patients, the QT interval adaptation to heart rate was
significantly slower than in survivors. An increase in adaptation speed on A might be an
explanation for the antiarrhythmic efficacy of the drug. 
1015-222 Electrocardiographic Progression of Arrhythmogenic 
Right Ventricular Dysplasia/Cardiomyopathy
Chandra Bomma, Jonathan Piccini, Darshan Dalal, Daniyal Ahmed, Harikrishna Tandri, 
Khurram Nasir, Crystal Tichnell, Cynthia James, Julie Rutberg, Hugh Calkins, Johns 
Hopkins University School of Medicine, Baltimore, MD
Back Ground: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a
genetic cardiomyopathy characterized by fatty fibrous replacement of right ventricle (RV).
Symptoms vary from ventricular arrhythmias to sudden cardiac death. The diagnosis of
ARVD/C is based on International Task Force criteria (TFC). Although ARVD/C is consid-
ered to be a progressive condition, few data are available concerning the rate and extent
of progression of this condition over time. The purpose of this study was to determine
whether serial electrocardiographic (ECG) evaluations demonstrate evidence of progres-
sion of ARVD/C.
Methods and Results: The study population included (32) individuals (13 males; mean
age 36±14 years) who were diagnosed with ARVD/C using the TFC. We analyzed the 12
lead ECG at two time points, separated by a median of 40 months. Progression on ECG
was defined as new T-wave inversion beyond the extent of T-wave inversion at baseline,
QRS progression of greater than 10 milliseconds duration over QRS duration at baseline,
development of a new bundle branch block (BBB), and/or the appearance of a new Epsi-
lon wave. Overall, ECG progression was observed in 20(62.5%) patients. T-wave pro-
gression was seen in 12(37.5%), QRS duration progression was seen in 4(12.5%)
patients and a new BBB was seen in 4(12.5%) patients. Epsilon wave was seen in one
patient and no new epsilon wave is seen in any of the patients.
Conclusion: The results of this study demonstrate that more than 50% of patients with
ARVD/C demonstrate evidence of progression of the disease by ECG criteria. Further
research is needed to determine what behavioral, clinical, and genetic factors best pre-
dict disease progression.
1015-223 T Wave Morphology Abnormalities Are Associated With 
Clinical Outcome in Hypertrophic Cardiomyopathy
Yi Gang, Katerina Hnatkova, Juan Gimeno, Marek Malik, St. George's Hospital Medical 
School, London, United Kingdom
Background: T-wave morphology (TWM) analysis quantifies repolarization abnormali-
ties. This study evaluated the relation of TWM to risk factors (RF: a family history of sud-
den cardiac death (SD), a history of VF, recurrent syncope, non-sustained VT, an
abnormal blood pressure response on exercise, maximum left ventricular wall thickness
>30 mm) for SD and clinical outcome in patients (pts) with hypertrophic cardiomyopathy
(HC).
Methods: Digitised 12-lead ECGs were recorded from 157 HC pts (107 men, age 43±15
yrs) using a MACVU electrocardiograph (GE Medical Systems, US) with a sampling rate
of 500 Hz. Study pts were followed up for 60±44 months. Analysis of the digital ECG
recordings was performed in a fully automatic manner with custom-developed software
implemented on a personal computer. Three TWM indices were calculated: complexity
ratio (CR), the total cosine R-to-T (TCRT), and relative T-wave residuum (TWR%).
Results: TWR% and CR were significantly increased in pts with any RF (0.14±0.02,
0.25±0.02) or with >2 RF (0.11±0.01, 0.23±0.02) compared with pts without any RF
(0.06±0.01, 0.20±0.01) (p<0.05, p<0.01), respectively. TCRT values were significantly
lower in pts with cardiac event (cardiac death, VF, ICD discharge) or cardiac death com-
pared with event-free survivors (table). A weak and significant correlation was found
between TCRT and maximum left ventricular wall thickness (r=-0.23, p=0.004).
Conclusion: Abnormalities in TWM are associated with RF or clinical outcome in HC
pts. 
1015-224 ST-Segment Elevation in Lead AVR in Acute Myocardial 
Infarction-Clue to Circumflex Coronary Artery Origin for 
Inferior/Posterior Myocardial Infarction
Chandana Weerasinghe, Giselle Smith, Mano Senaratne, Grey Nuns Hospital-University 
of Alberta, Edmonton, AB, Canada
Background: Inferior/posterior acute myocardial infarctions(AMI ) can result from occlu-
sion of the right or circumflex coronary arteries. Right pre-cordial and posterior leads are
often useful in this differentiation. The present study evaluated the utility of ST-segment
elevation (STE) in lead aVR in this differentiation.
Methods: ST-segment change (approximated to the nearest 0.5mm once a minimum of
0.5mm of deviation was identified) was measured with the naked eye on the presenting
electrocardiogram(EKG) in 561 consecutive pts with AMI (M=408, F=153; age: mean
64.8±0.6 yrs SEM). All the EKGs were evaluated by one individual who was blinded to
the rest of the clinical and investigational data. In all leads STE of 0.5 mm or more was
considered significant. All data were collected prospectively.
Results: 137 patients (24.4%) demonstrated STE in aVR with 17.3%, 26.4%, 38.7%, and
42.0% incidences in inferior, antero-septal, posterior, and lateral AMI’s respectively
(p<0.001). Those with STE in aVR had higher magnitudes of ST-segment depression
(STD) in leads I, II, V1, V2, V4, aVL and higher magnitudes of STE in leads II, III, aVF,
V5, V6 (p<0.01). The presence of STE in the right pre-cordial leads was not significantly
associated with STE aVR (p>0.05). In patients in whom an angiogram was done within
the hospital stay (138 pts=24.6%) STE in aVR was present in 15.4%, 30.8%, 52.4%, and
60.0% of patients with the culprit lesion in the right coronary, left anterior descending, cir-
cumflex, and obtuse marginal arteries respectively (p=0.003). STE in aVR appeared to
be associated with significantly lower creatine kinase peaks (1214±123 u/l vs. 1753±152
u/l, p=0.05) with a trend towards a lower in-hospital mortality (2.9% vs. 5.9%) and one-
year coronary event rates (18.7% vs. 28.1%, p=0.09).
Conclusions: STE in aVR is more often associated with inferior and/or posterior AMI’s
caused by a circumflex coronary artery occlusion (as opposed to a right coronary artery
occlusion). Thus, it may serve as a useful additional marker to help in this differentiation.
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1034-207 Mechanism for Rate Slowing by Anterior 
Atrioventricular Node Modification During Atrial 
Fibrillation: Partial Damage of the Compact Node 
Rather Than Fast Pathway Ablation
Youhua Zhang, Saroja Bharati, Rabi Sulayman, Todor N. Mazgalev, The Cleveland Clinic 
Foundation, Cleveland, OH, Hope Children's Hospital, Oak Lawn, IL
Background: We have demonstrated that selective fast pathway (FP) ablation has no
effect on ventricular rate (VR) in atrial fibrillation (AF). This appears to contradict reports
of VR slowing in about 1/3 of patients using anterior approach. We hypothesized that
such clinical outcome results from inadvertent damage of the compact atrioventricular
node (AVN).
Methods: His electrogram alternans (Circ 2003;107:1059) was used to monitor the dual
pathway conduction during AF in 12 rabbits. The FP conduction resulted in low amplitude
inferior His electrogram (IHE), while slow pathway (SP) - in high IHE. After successful
selective FP ablation, further lesions were applied progressively closer to the compact
AVN. The ablation sites were studied by detailed morphological sectioning.
Results: Both FP and SP conducted beats (Figure A, low and high IHE) were present
during AF. Selective FP ablation revealed only-SP conduction (B, high IHE), but didn’t
change VR (298±18 vs 301±14 bpm, P>0.05). Ablations closer to AVN resulted in SP-
rate slowing (C) and ultimately in AVN block (not shown). Morphological evidence indi-
cated that VR slowing occurred only when lesions extended into the compact AVN
domain resulting in a non-selective, FP plus SP, modification.
Conclusion: Selective FP ablation has no effect on VR in AF. Slower VR could be
TCRT (mean±sem) positive negative P value
Cardiac events (n=14) -0.67±0.09 –0.43±0.04 0.030
Cardiac death (n=9) -0.71±0.12 –0.43±0.04 0.035
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achieved only after collateral damage of the compact AVN. This study highlights the use-
fulness of HE alternans as a novel index to monitor AVN dual pathways and modification.
1034-208 Enalapril Can Prevent Perpetuation of Atrial Fibrillation 
Through Suppression of Interstitial Fibrosis and 
Connexin43 Expression Associated With Shortening of 
Excitable Gap in a Canine Rapid Atrial Pacing Model 
With Tachycardia-Mediated Cardiomyopathy
Masao Sakabe, Akira Fujiki, Kunihiro Nishida, Hidehiko Nagasawa, Koichi Mizumaki, 
Hiroshi Inoue, Toyama Medical and Pharmaceutical University, Toyama, Japan
Effects of enalapril on pacing-induced canine atrial fibrillation (AF) with rapid ventricular
responses were investigated. Methods: Twenty-one beagles were pretreated with pla-
cebo (G-I, n=14) or enalapril 1mg/kg (G-II, n=7). All beagles were paced at 500bpm from
the right atrial appendage for 4 weeks. Ventricular rate during pacing was similar (G-I
272.9±47.8bpm vs. G-II 279.5±33.4bpm:N.s). Atrial effective refractory period (AERP),
averaged P-wave width, inducibility of AF and duration of induced-AF were evaluated
every week. Spectral analyses of fibrillation waves were performed to evaluate AF cycle
length (FCL). The excitable gap (EG) was defined as FCL minus the shortest cycle length
producing atrial capture. Left ventricular ejection fraction (LVEF) was measured with tran-
sthoracic echocardiography. After 4 weeks pacing, tissues were stained with Masson’s
trichrome and Connexin (Cx)43 and quantitative analysis was performed.
Results: The shortening of AERP after one week pacing did not differ (G-I 30.7±6.0%, G-
II 25.6±17.5%). The inducibility of AF after 4 weeks pacing was similar, but the duration
was significantly shorter in G-II (3.6±3.4sec ) compared with G-I (58.0±60.0sec: p<0.05).
The P-wave width was shorter in G-II (75.3±6.5ms) than G-I (85.5±13.0ms: p<0.05). FCL
and EG were shorter in G-II (FCL 116.6±1.5ms, EG 14.1±10.3ms) than G-I (FCL
134.5±20.2ms: p<0.05, EG 34.7±14.1ms: p<0.05). LVEF was significantly decreased
and it was similar in both groups (G-I 37.5±15.6%, G-II 37.4±1.2%). There were signifi-
cant decrease in both interstitial fibrosis (IF) and Cx43 in G-II compared with G-I (IF:
2.2±2.3% vs. 9.2±9.1%: p<0.05, Cx43: 1.1±1.2% vs. 5.3±2.2%: p<0.05). Conclusions:
Enalapril decreased prolongation of P-wave width and duration of AF owing to the sup-
pression of IF and over-expression of Cx43 in this model. During induced AF enalapril
decreased both FCL and EG without affecting AERP. These findings suggest enalapril
can prevent perpetuation of AF with tachycardia-mediated cardiomyopathy through
shortening of EG due to improvement of atrial conduction delay.
1034-209 Depression and Not Facilitation Governs the 
Atrioventricular Nodal Propagation: Insight From Dual 
Pathway Electrophysiology
Youhua Zhang, Todor N. Mazgalev, The Cleveland Clinic Foundation, Cleveland, OH
S1-S2-S3 atrial pacing protocols, with S1S2 interval interposed between basic S1 and
test impulse S3 (figure, inset), are widely used to study functional properties of atrioven-
tricular node (AVN). A controversial phenomenon, facilitation, has been observed with
shortening of S1S2. We investigated the properties of fast and slow pathway (FP, SP)
conduction, hypothesizing that facilitation reflects enhanced FP conduction when S1S2 is
shortened.
Methods: AVN conduction curves were generated by programmed pacing in 7 rabbit
hearts. For 3 S1S2 intervals (300, 150, 125 ms) conduction times S3H3 were plotted
against prematurities S2S3. The segments of the curves corresponding to FP or SP con-
duction were defined by applying the sensitive index of His electrogram alternans (Circ
2003; 107:1059).
Results: Shortening of the interposed S1S2 shifted all conduction curves up and right
(figure). AVN effective refractory period prolonged (102 ± 9 to 125 ± 14 to 156 ± 33 ms).
Most importantly, the transition from FP (thick segments) to SP (thin segments) occurred
at progressively longer test prematurity S2S3 (arrows, 175 ± 36 to 203 ± 42 to 244 ± 45
ms). Therefore, shortening of S1S2 did not facilitate any of the pathways. In contrast,
there was either depression of FP (at Long S2S3), or block of FP and shift to SP (at Inter-
mediate S2S3), or depression of SP (at Short S2S3).
Conclusion: Depression, not facilitation, is fundamental AVN property revealed by short
interposed S1S2 intervals that produce inhibition of both the FP and SP.
1034-210 Mapping of Successful and Failed Atrial Defibrillation
Xiangsheng Zheng, Gregory P. Walcott, Raymond E. Ideker, University of Alabama at 
Birmingham, Birmingham, AL
We electrically mapped atrial defibrillation in 10 sheep with sustained atrial fibrillation
induced electrically after pericardial infusion of methylcholine. Biphasic shocks (3-1 ms)
with a peak voltage 5-10% lower than the atrial defibrillation threshold were delivered to
right atrial and coronary sinus electrodes. In the first 8 sheep global atrial mapping was
performed with 504 electrodes spaced 3-4 mm apart. Seventeen successful shocks were
"type B" in which 1 or more rapid activations appeared after the shock. A long interval
was present between the shock and earliest postshock activation for all episodes but was
longer for type B (113±32 ms) then for failed (74±25 ms, p<0.05) episodes. In all type B
and 17 of 24 failed episodes, activation spread way from the earliest activation in a focal
pattern. In none of the type B and in 7 of the failed episodes, a region of approximately 10
to 40 electrodes with fragmented and double potentials exhibited earliest postshock acti-
vation. In those 17 failed episodes in which earliest activation was focal and in none of
the type B episodes, regions of fragmented electrograms were observed during later acti-
vation cycles. Since the electrode spacing was too great in the global maps to map acti-
vation in the fragmented regions, in 2 additional sheep a 504 electrode plaque with 1.5
mm electrode spacing was placed on the right atrial appendage and all postshock epi-
sodes were analyzed. In 11 episodes in which earliest activation appeared inside the
plaque, earliest activation was focal in 10. In the remaining 1 episode in which the earliest
activated region exhibited fragmented electrograms, reentry could be identified. In those
10 failed episodes in which earliest activation was focal, regions of fragmented electro-
grams were observed during later activation cycles and reentry could be identified in 5.
Thus, (1) earliest recorded postshock activation follows a relatively long interval after the
shock and is longer for type B than failed episodes, (2) earliest activation following all
type B and most failed episodes is focal, and (3) all failed but no type B episodes exhibit
regions of fragmented electrograms which may represent reentry.
1034-211 Neutrophil Infiltration as an Inflammatory Mechanism 
Promoting Atrial Fibrosis in Atrial Fibrillation
David R. Van Wagoner, Rachel Jamison, Marie-Luise Brennan, Mina K. Chung, A. Marc 
Gillinov, Cleveland Clinic Foundation, Cleveland, OH
Background: We have postulated that inflammation contributes to structural remodeling
that increases the persistence of atrial fibrillation (AF). Myocyte loss (apoptotic or
necrotic) and replacement fibrosis are key elements of this process. Injured myocardium
releases cytokines that recruit neutrophil and macrophage infiltration. Neutrophils help to
remove necrotic or apoptotic myocytes. Myeloperoxidase (MPO) is an abundant neutro-
phil marker. In this study, we tested the hypothesis that atrial fibrosis is increased in the
atria of AF patients, and that neutrophil infiltration was correlated with the extent of fibro-
sis.
Methods: Sections of left atrial appendage (LAA) were characterized from patients
undergoing cardiac surgery (Maze surgery for AF, and/or mitral valve repair). Maze LAA
(n=11) were from persistent AF patients. Control LAA (n=4) were from patients in normal
sinus rhythm undergoing mitral valve repair. LAA were formalin-fixed, blocked and
mounted for histologic analysis. Adjacent sections from each appendage were stained
either with Masson’s trichrome stain (to quantify fibrosis) or with an antibody to MPO.
Fibrosis was quantified as the fraction of muscle bundles in cross-sections stained blue,
using NIH Image analysis software.
Results: Interstitial fibrosis was significantly increased in AF tissues (47±6%) vs. con-
trols (29±5%, p<0.001). In AF LAA, the correlation between extent of fibrosis and age
was weak. Mean ages of the groups were similar (controls 66.3 years, AF 58 years).
MPO staining was detectable in LAA from 4/11 AF patients. Inflammatory infiltration was
typically most apparent at the border of normal myocardium and endocardial fibrosis,
suggesting a causal relationship between the inflammatory process and development of
fibrosis. Among the AF LAA, those with abundant MPO+ cells had significantly higher
interstitial fibrosis (51±1%) relative to those without MPO staining (44±2%, p=0.037). 
Conclusions: Low-level inflammation accompanying persistent AF likely reflects ongo-
ing apoptosis and replacement fibrosis. MPO staining suggests that neutrophil activation
has a prominent role in the structural remodeling that promotes AF persistence.
